Alfred Mertens

This inventor holds 33 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Boehringer Mannheim Gmbh, Hoffmann-La Roche Inc., Roche Diagnostics Gmbh. Active years: 1987-2021.

USPTO Granted Patents = 33 (Patent Applications = 3)

% Patents Active = 93.9

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.4

ph-index = 11

Forward Citations = 483(Granted Patents)

Company Filing History:

30 out of 1,164

Boehringer Mannheim Gmbh

patents

1 out of 5,020

Hoffmann-La Roche Inc.

patents

1 out of 487

Roche Diagnostics Gmbh

patents

4. 1 out of 1,696

Roche Diagnostics Operations, Inc.

patents

Years Active: 1987-2021

Loading Chart...

Areas of Expertise:

Antiviral Agents

Benzimidazole Compounds

Nucleoside Derivatives

Thiazolidinediones

Isoquinoline Derivatives

Phospholipid Derivatives

Purine Analog Compounds

Tricyclic Compounds

Heterocyclic Substituted Indoles

Pyrrolobenzimidazoles

Cardiotonic Agents

Pharmaceutical Compositions

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10982007 - Detection of a posttranslationally modified polypeptide by a bivalent binding agent (2021-04-20),

2. 7572809 - Isoquinoline aminopyrazole derivatives (2009-08-11),

3. 6025343 - Lipid esters of nucleoside monophosphates and their use as (2000-02-15),

4. 5786371 - Pyridine and pyridazine derivatives, processes for the production (1998-07-28),

5. 5756711 - Phospholipid derivatives of nucleosides and their use as anti-viral (1998-05-26),

6. 5599826 - Thiazolidinediones and drugs containing them (1997-02-04),

7. 5563257 - Phospholipid derivatives of nucleosides (1996-10-08),

8. 5512564 - Tricyclic thiazole and oxazole derivatives and pharmaceutical agents (1996-04-30),

9. 5446139 - Purine analog nucleoside and nucleotide compounds (1995-08-29),

10. 5397794 - Use of thiazoloisoindolinone derivatives as antiviral medicaments (1995-03-14),

11. 5373019 - Pharmaceutical lactam compositions for inhibition of erythrocyte and (1994-12-13),

12. 5135949 - Pharmaceutical compositions containing phenylamides (1992-08-04),

13. 5116843 - Tricyclic benzimidazole compounds, pharmaceutical compositions and (1992-05-26),

14. 5019587 - Bicyclic carboxamides, compositions containing same and use thereof (1991-05-28),

15. 4985448 - Ureidoindoles, pharmaceutical compositions and methods for erythrocyte (1991-01-15),

Title: Alfred Mertens - Innovative Inventor from Schriesheim

Introduction: Alfred Mertens is a renowned inventor hailing from Schriesheim, Germany, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Alfred Mertens holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced manufacturing processes, showcasing his commitment to driving progress through innovation.

Career Highlights: Throughout his illustrious career, Alfred Mertens has worked tirelessly to develop cutting-edge solutions that have revolutionized industries, earning him a reputation as a visionary inventor with a passion for pushing boundaries.

Collaborations: Alfred Mertens has collaborated with leading research institutions, universities, and companies worldwide to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams to achieve common goals.

Conclusion: Alfred Mertens' dedication to innovation and his relentless pursuit of excellence have solidified his position as a pioneering inventor whose impact will be felt for years to come.